20 May 2013
Keywords: zeffix, effective, hbv, children, biochem, pharma, says
Article | 24 April 2001
BioChem Pharma says that its oral antiviral Zeffix (lamivudine),licenced to GlaxoSmithKline, is effective at suppressing hepatitis B in
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 April 2001
25 April 2001
17 May 2013
© 2013 thepharmaletter.com